Literature DB >> 12692243

Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells.

Olivier Rohr1, Dominique Lecestre, Sylvette Chasserot-Golaz, Céline Marban, Dorina Avram, Dominique Aunis, Mark Leid, Evelyne Schaeffer.   

Abstract

The Tat protein of human immunodeficiency virus type 1 (HIV-1) plays a key role as inducer of viral gene expression. We report that Tat function can be potently inhibited in human microglial cells by the recently described nuclear receptor cofactor chicken ovalbumin upstream promoter transcription factor-interacting protein 2 (CTIP2). Overexpression of CTIP2 leads to repression of HIV-1 replication, as a result of inhibition of Tat-mediated transactivation. In contrast, the related CTIP1 was unable to affect Tat function and viral replication. Using confocal microscopy to visualize Tat subcellular distribution in the presence of the CTIPs, we found that overexpression of CTIP2, and not of CTIP1, leads to disruption of Tat nuclear localization and recruitment of Tat within CTIP2-induced nuclear ball-like structures. In addition, our studies demonstrate that CTIP2 colocalizes and associates with the heterochromatin-associated protein HP1alpha. The CTIP2 protein harbors two Tat and HP1 interaction interfaces, the 145-434 and the 717-813 domains. CTIP2 and HP1alpha associate with Tat to form a three-protein complex in which the 145-434 CTIP2 domain interacts with the N-terminal region of Tat, while the 717-813 domain binds to HP1. The importance of this Tat binding interface and of Tat subnuclear relocation was confirmed by analysis of CTIP2 deletion mutants. Our findings suggest that inhibition of HIV-1 expression by CTIP2 correlates with recruitment of Tat within CTIP2-induced structures and relocalization within inactive regions of the chromatin via formation of the Tat-CTIP2-HP1alpha complex. These data highlight a new mechanism of Tat inactivation through subnuclear relocalization that may ultimately lead to inhibition of viral pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692243      PMCID: PMC153947          DOI: 10.1128/jvi.77.9.5415-5427.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Nuclear lamins: building blocks of nuclear architecture.

Authors:  Robert D Goldman; Yosef Gruenbaum; Robert D Moir; Dale K Shumaker; Timothy P Spann
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

Review 2.  Nuclear compartments and gene regulation.

Authors:  M Cockell; S M Gasser
Journal:  Curr Opin Genet Dev       Date:  1999-04       Impact factor: 5.578

3.  Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin.

Authors:  K E Brown; S S Guest; S T Smale; K Hahm; M Merkenschlager; A G Fisher
Journal:  Cell       Date:  1997-12-12       Impact factor: 41.582

4.  Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9.

Authors:  Peter R Nielsen; Daniel Nietlispach; Helen R Mott; Juliana Callaghan; Andrew Bannister; Tony Kouzarides; Alexey G Murzin; Natalia V Murzina; Ernest D Laue
Journal:  Nature       Date:  2002-02-20       Impact factor: 49.962

5.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.

Authors:  C Dingwall; I Ernberg; M J Gait; S M Green; S Heaphy; J Karn; A D Lowe; M Singh; M A Skinner; R Valerio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat.

Authors:  M Benkirane; R F Chun; H Xiao; V V Ogryzko; B H Howard; Y Nakatani; K T Jeang
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

7.  Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.

Authors:  V Doucas; M Tini; D A Egan; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

8.  Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat.

Authors:  Guocheng He; David M Margolis
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

9.  Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.

Authors:  R F Chun; O J Semmes; C Neuveut; K T Jeang
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

10.  Intracellular trafficking and interactions of the HIV-1 Tat protein.

Authors:  R H Stauber; G N Pavlakis
Journal:  Virology       Date:  1998-12-05       Impact factor: 3.616

View more
  44 in total

1.  Novel nuclear herniations induced by nuclear localization of a viral protein.

Authors:  Cristen C Hoyt; Ron J Bouchard; Kenneth L Tyler
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis.

Authors:  Mark Leid; Jane E Ishmael; Dorina Avram; David Shepherd; Valérie Fraulob; Pascal Dollé
Journal:  Gene Expr Patterns       Date:  2004-10       Impact factor: 1.224

Review 3.  Functional roles of HIV-1 Tat protein in the nucleus.

Authors:  Yana R Musinova; Eugene V Sheval; Carla Dib; Diego Germini; Yegor S Vassetzky
Journal:  Cell Mol Life Sci       Date:  2015-10-27       Impact factor: 9.261

Review 4.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

5.  Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing.

Authors:  Céline Marban; Stella Suzanne; Franck Dequiedt; Stéphane de Walque; Laetitia Redel; Carine Van Lint; Dominique Aunis; Olivier Rohr
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

6.  CTIP2 is a negative regulator of P-TEFb.

Authors:  Thomas Cherrier; Valentin Le Douce; Sebastian Eilebrecht; Raphael Riclet; Céline Marban; Franck Dequiedt; Yannick Goumon; Jean-Christophe Paillart; Mathias Mericskay; Ara Parlakian; Pedro Bausero; Wasim Abbas; Georges Herbein; Siavash K Kurdistani; Xavier Grana; Benoit Van Driessche; Christian Schwartz; Ermanno Candolfi; Arndt G Benecke; Carine Van Lint; Olivier Rohr
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-12       Impact factor: 11.205

Review 7.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

8.  Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression.

Authors:  Thanaset Senawong; Valerie J Peterson; Dorina Avram; David M Shepherd; Roy A Frye; Saverio Minucci; Mark Leid
Journal:  J Biol Chem       Date:  2003-08-19       Impact factor: 5.157

Review 9.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

10.  In vitro nuclear interactome of the HIV-1 Tat protein.

Authors:  Virginie W Gautier; Lili Gu; Niaobh O'Donoghue; Stephen Pennington; Noreen Sheehy; William W Hall
Journal:  Retrovirology       Date:  2009-05-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.